Skip to main content

Peer Review reports

From: Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer

Original Submission
26 Sep 2018 Submitted Original manuscript
22 Oct 2018 Reviewed Reviewer Report - Shabbir Alibhai
10 Feb 2019 Reviewed Reviewer Report - Martin Boegemann
12 Mar 2019 Author responded Author comments - Joshua Philip Schiff
Resubmission - Version 2
12 Mar 2019 Submitted Manuscript version 2
14 Apr 2019 Author responded Author comments - Joshua Philip Schiff
Resubmission - Version 3
14 Apr 2019 Submitted Manuscript version 3
8 May 2019 Author responded Author comments - Joshua Philip Schiff
Resubmission - Version 4
8 May 2019 Submitted Manuscript version 4
13 May 2019 Author responded Author comments - Joshua Philip Schiff
Resubmission - Version 5
13 May 2019 Submitted Manuscript version 5
Publishing
17 May 2019 Editorially accepted
31 May 2019 Article published 10.1186/s12885-019-5729-7

You can find further information about peer review here.

Back to article page